Literature DB >> 646255

Tear-duct fibrosis (dacryostenosis) due to 5-fluorouracil.

D J Haidak, B S Hurwitz, K Y Yeung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 646255     DOI： 10.7326/0003-4819-88-5-657_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Bilateral total corneal epithelial erosion as a side effect of cytotoxic therapy.

Authors:  A Hirsh; A Alhalel; A Weiss; H Brener; I Avni
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

2.  Clinical features and treatment outcomes of patients with tearing after chemotherapy.

Authors:  Jinhwan Park; Joohyun Kim; Sehyun Baek
Journal:  Eye (Lond)       Date:  2018-12-10       Impact factor: 3.775

3.  Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.

Authors:  P Kaynak; G O Karabulut; C Ozturker; K Fazil; Y O Arat; I Perente; S Akar; O F Yilmaz; A Demirok
Journal:  Eye (Lond)       Date:  2016-05-20       Impact factor: 3.775

4.  5-Fluorouracil and ocular toxicity.

Authors:  J E Forbes; D J Brazier; M Spittle
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

5.  Iris crystals and uveitis.

Authors:  P I Murray
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

6.  Fractured laser fibreoptic cord.

Authors:  J Singh; K Swa
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

Review 7.  Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.

Authors:  H M Brink; L V Beex
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

8.  Predictive factors for ocular complications caused by anticancer drug S-1.

Authors:  Rika Yamada; Chie Sotozono; Takahiro Nakamura; Akihiro Nishida; Shinya Nakanishi; Masaki Hirabatake; Akihito Tsuji; Yasuo Kurimoto
Journal:  Jpn J Ophthalmol       Date:  2016-02-03       Impact factor: 2.447

Review 9.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.